Technology Platforms

Developing Products to Meet Patient Needs

At Aptalis Pharmaceutical Technologies, we endeavor to develop products that offer maximum value to our customers by providing therapeutic benefits for patient needs.

Our formulation scientists leverage our multiple technology platforms – and range of technologies within each platform – to assist our partners in meeting those patient needs.

 

 

 

 

Pharmaceutical Technology Platforms	Technologies within Platforms
Taste Masking and ODTs Our proprietary technologies provide taste-masked products with a pleasant taste and excellent mouth-feel for patient appeal, available in a variety of presentation forms including our AdvaTab® Orally Disintegrating Tablets (ODT).	AdvaTab® Microcaps® Liquitard®
Customized Drug Release The platform consists of a range of technologies that provide a wide variety of customized release profiles that can be tailored to optimize a drug’s therapeutic performance by improving efficacy and/or enhancing safety. Patient acceptability and compliance can be increased through less frequent dosing.	Diffucaps® Diffutab® Orbexa® Eurand Minitabs® Microcaps®
Bioavailability Enhancement We offer technologies to enable and improve the bioavailability of drugs with low solubility or an extreme pH-dependent solubility profile. The resulting formulations can provide effective oral dosing of poorly soluble drug candidates, equivalent therapy at lower doses, faster onset of action, and/or minimization of food effect.	Biorise® Diffucaps®